Skip to main content
Markus Mapara, MD, Oncology, New York, NY

MarkusYMaparaMDPhD

Oncology New York, NY

Hematologic Oncology

Professor of Medicine, Director of Blood and Marrow Transplantation, Columbia University Medical Center, New York

Overview of Dr. Mapara

Dr. Markus Mapara is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Heidelberg Faculty of Medicine and has been in practice 27 years. Dr. Mapara accepts several types of health insurance, listed below. He is one of 378 doctors at New York-Presbyterian Hospital and one of 116 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He also speaks multiple languages, including German and French. He has more than 100 publications and over 500 citings.

Education & Training

  • University of Heidelberg Faculty of Medicine
    University of Heidelberg Faculty of MedicineClass of 1990

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2011 - 2025
  • PA State Medical License
    PA State Medical License 2005 - 2014
  • Internal MedicineHematology/Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Immunomodulatory Drugs Downregulate IKZF1 Leading to Expansion of Hematopoietic Progenitors with Concomitant Block of Megakaryocytic Maturation  
    Markus Y Mapara, Sara A Monaghan, Suzanne Lentzsch, Haematologica
  • Brentuximab Vedotin and Bendamustine Produce High Complete Response Rates in Patients with Chemotherapy Refractory Hodgkin Lymphoma  
    Changchun Deng, Markus Y. Mapara, Ahmed Sawas, Matko Kalac, British Journal of Haematology

Abstracts/Posters

  • Combination Chemotherapy with Carfilzomib, Bendamustine and Dexamethasone Is Highly Active for Therapy of Newly Diagnosed Multiple Myeloma-Results of Single Center Pha...
    Markus Y. Mapara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Excellent Survival and Immune Reconstitution Following Matched/Mismatched Unrelated and Mismatched Related Transplantation in Adult Patients with Sickle Cell Disease: ...
    Markus Y Mapara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Exploring the Drivers of Potential Clinical Benefit in Initial Patients Treated in the Hgb-206 Study of Lentiglobin for Sickle Cell Disease (SCD) Gene Therapy
    Markus Y. Mapara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Outcomes for Initial Patient Cohorts with up to 33 Months of Follow-up in the Hgb-206 Phase 1 Trial 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Actinium Announces FDA Clearance of Iomab-ACT Targeted Conditioning IND Application for Sickle Cell Disease Patients Undergoing Bone Marrow Transplant in Collaboration with Columbia University
    Actinium Announces FDA Clearance of Iomab-ACT Targeted Conditioning IND Application for Sickle Cell Disease Patients Undergoing Bone Marrow Transplant in Collaboration with Columbia UniversityJuly 25th, 2024
  • A Gene Therapy Cure for Sickle Cell Is on the Horizon
    A Gene Therapy Cure for Sickle Cell Is on the HorizonMarch 15th, 2023
  • Boston University Reveals New Treatment for Sickle Cell Anemia
    Boston University Reveals New Treatment for Sickle Cell AnemiaApril 9th, 2022
  • Join now to see all

Grant Support

  • Role Of STAT1 And STAT3 In Graft Versus Host Disease And Graft Versus Leukemia EFNational Heart, Lung, And Blood Institute2008–2011

Professional Memberships

Other Languages

  • German, French

Insurance Accepted

  • Empire BCBS PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment